Guided Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Guided Therapeutics generated cash of -$1,746,000, which is less than the previous year. Cash used in financing activities reached the amount of $24,000 last year. Net change in cash is therefore -$1,722,000.
Cash Flow
| 2014 | -6.28M | -150K | 5.98M |
|---|---|---|---|
| 2015 | -4.04M | -8K | 3.92M |
| 2016 | -1.80M | 0 | 1.78M |
| 2017 | -1.14M | 0 | 1.13M |
| 2018 | -1.36M | 0 | 1.36M |
| 2019 | -806K | 0 | 1.70M |
| 2020 | -1.87M | -1K | 1.15M |
| 2021 | -1.59M | -14K | 2.06M |
| 2022 | -1.47M | -31K | 3.18M |
| 2023 | -1.74M | 0 | 24K |
GTHP Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.31M | 643K | 182K | 899K | 0 | 1K | 14K | 35K | 162K | 613K |
Operating activities | ||||||||||
Net income | -3.48M | -4.34M | -2.07M | -279K | -1.92M | 1.01M | -10.69M | -3.97M | -6.90M | -9.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 85K | 72K | 83K | 0 | 21K | 27K | 213K | 1.22M | 1.05M | 483K |
Stock-based compensation expense | 1.80M | 1.38M | 228K | 310K | 8K | 0 | 59K | 95K | 1.40M | 886K |
| Deferred income tax benefit | 1.80M | 1.38M | 228K | 310K | 8K | 0 | 59K | 95K | 1.40M | 886K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3K | 16K | -22K | -23K | 1.14M | -10K | -9K | -31K | 129K | -267K |
Inventories | -84K | -58K | 33K | -483K | 66K | 151K | 508K | 345K | 61K | 14K |
Accounts payable | 43K | 123K | -229K | -372K | 20K | -6K | 420K | 775K | 91K | 842K |
Cash generated by operating activities | -1.74M | -1.47M | -1.59M | -1.87M | -806K | -1.36M | -1.14M | -1.80M | -4.04M | -6.28M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -31K | -14K | -1K | 0 | 0 | 0 | 0 | -8K | -150K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -31K | -14K | -1K | 0 | 0 | 0 | 0 | -8K | -150K |
Financing activities | ||||||||||
Common Stock Issued | 436K | 1.39M | 2.1M | 1.74M | 635K | 0 | 1.57M | 50K | 720K | 1.73M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -125K | 0 | 0 | 0 | 0 | 1.02M | 0 | 0 |
Repayments of term debt | 0 | 0 | -92K | -1.10M | 1.07M | -1.38M | -441K | -227K | -637K | -656K |
Cash used in financing activities | 24K | 3.18M | 2.06M | 1.15M | 1.70M | 1.36M | 1.13M | 1.78M | 3.92M | 5.98M |
Net Change In Cash | -1.72M | 1.67M | 461K | -717K | 899K | -1K | -13K | -21K | -127K | -451K |
Cash at end of period | 591K | 2.31M | 643K | 182K | 899K | 0 | 1K | 14K | 35K | 162K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |